CA2277770A1 - Drug delivery balloon catheter device - Google Patents
Drug delivery balloon catheter device Download PDFInfo
- Publication number
- CA2277770A1 CA2277770A1 CA002277770A CA2277770A CA2277770A1 CA 2277770 A1 CA2277770 A1 CA 2277770A1 CA 002277770 A CA002277770 A CA 002277770A CA 2277770 A CA2277770 A CA 2277770A CA 2277770 A1 CA2277770 A1 CA 2277770A1
- Authority
- CA
- Canada
- Prior art keywords
- balloon
- sheath
- drug
- tab
- opening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
Abstract
This invention is a medical device for delivering a drug internally to a patient's body. The medical device includes a catheter (4) with a catheter shaft (5) and a balloon (6) attached to a distal end of the catheter shaft (5), and a flexible, thin-walled sheath (10) extending over the balloon (6). The sheath (10) includes a balloon enveloping portion (12) having an inner diameter sized to fit closely around the balloon (6) and a collar (14) distal to, and having an inner diameter slightly smaller than the inner diameter of the balloon enveloping portion (12). The collar (14) terminates in an opening, and a tab (22) extends distally from a wall of the sheath (10).
Description
WO 9&/31415 PCTIUS98I00373 DRUG DELIVERY BALLOON CATHE~'ER DEVICE
This app~ication relates to delivering drugs internally to a patient's body.
Hackctround oil the Invention Balloon catheters may be used to deliver drugs to tissue at a desired location of a body lumen or cavity.
Typically, the balloon is positioned at the desired location for drug delivery by sliding it through portions of the body lumen or cavity where no drug delivery is desired. Consequently, it may be difficult to avoid undesired drug release during the positioning of the balloon, particularly when the body lumen or cavity transports bodily fluids into which the drug may be released.
U.S. Patent No. 5,304,121 describes a drug delivery system that uses a hydrogel coating. The '121 patent discloses a rigid sheath member extendable over the hydrogel coating to help prevent the release of the drug into bodily fluids. The entire disclosure of the '121 patent is hereby incorporated herein by reference.
Summary of the Invent,~on One aspect of the invention generally features a medical device for delivering a drug internally to a patient's body. The device includes a catheter with a catheter shaft and a balloon attached to a distal end of the catheter shaft and a flexible, thin-walled sheath extending over the balloon. The sheath helps to prevent the premature release of the drug during the positioning of the balloon at the desired location for drug delivery.
Because the sheath is flexible and thin-walled, the flexibility and outer diameter of the catheter are only minimally affected by the addition of the sheath.
The sheath includes a balloon-enveloping portion having an inner diameter sized to fit closely around the
This app~ication relates to delivering drugs internally to a patient's body.
Hackctround oil the Invention Balloon catheters may be used to deliver drugs to tissue at a desired location of a body lumen or cavity.
Typically, the balloon is positioned at the desired location for drug delivery by sliding it through portions of the body lumen or cavity where no drug delivery is desired. Consequently, it may be difficult to avoid undesired drug release during the positioning of the balloon, particularly when the body lumen or cavity transports bodily fluids into which the drug may be released.
U.S. Patent No. 5,304,121 describes a drug delivery system that uses a hydrogel coating. The '121 patent discloses a rigid sheath member extendable over the hydrogel coating to help prevent the release of the drug into bodily fluids. The entire disclosure of the '121 patent is hereby incorporated herein by reference.
Summary of the Invent,~on One aspect of the invention generally features a medical device for delivering a drug internally to a patient's body. The device includes a catheter with a catheter shaft and a balloon attached to a distal end of the catheter shaft and a flexible, thin-walled sheath extending over the balloon. The sheath helps to prevent the premature release of the drug during the positioning of the balloon at the desired location for drug delivery.
Because the sheath is flexible and thin-walled, the flexibility and outer diameter of the catheter are only minimally affected by the addition of the sheath.
The sheath includes a balloon-enveloping portion having an inner diameter sized to fit closely around the
- 2 -balloon and a collar distal to, and having an inner diameter slightly smaller than the inner diameter of, the balloon-enveloping portion. The collar terminates in an opening. The collar has a slightly smaller inner diameter to help prevent the balloon from sliding out of the opening during the positioning of the balloon at the desired location for drug delivery.
To facilitate the use of a flexible, thin-walled sheath which might otherwise be difficult to manipulate in certain operations described below in which the relative positions of the sheath and balloon are adjusted, a tab extends distally from the wall of the sheath. The tab also may be a continuation of part of the wall of the sheath. The tab is used to adjust the sheath with respect to the catheter. Because the tab should be removed before the device is inserted into the patient's body, the sheath may have pre-formed cuts located where the tab is attached to the sheath. The tab is detachable from the sheath by tearing the sheath along the pre-formed cuts.
The sheath also may have indentations located at the balloon-enveloping portion to engage the balloon.
The indentations are transverse to the balloon axis and help to prevent the balloon from sliding out of the opening during the positioning of the balloon at the desired location for drug delivery.
The wall of the sheath has a thickness ~of no more than 0.04 French. Also, the sheath may be made from polyester, nylon or polyethylene terephthalate (PET).
In another aspect, the invention generally features a device in which the balloon is coated with a hydrogel polymer matrix having a drug embedded therein.
In yet another aspect, the invention generally features a method for delivering a drug internally to a patient's body by providing the above-described device;
To facilitate the use of a flexible, thin-walled sheath which might otherwise be difficult to manipulate in certain operations described below in which the relative positions of the sheath and balloon are adjusted, a tab extends distally from the wall of the sheath. The tab also may be a continuation of part of the wall of the sheath. The tab is used to adjust the sheath with respect to the catheter. Because the tab should be removed before the device is inserted into the patient's body, the sheath may have pre-formed cuts located where the tab is attached to the sheath. The tab is detachable from the sheath by tearing the sheath along the pre-formed cuts.
The sheath also may have indentations located at the balloon-enveloping portion to engage the balloon.
The indentations are transverse to the balloon axis and help to prevent the balloon from sliding out of the opening during the positioning of the balloon at the desired location for drug delivery.
The wall of the sheath has a thickness ~of no more than 0.04 French. Also, the sheath may be made from polyester, nylon or polyethylene terephthalate (PET).
In another aspect, the invention generally features a device in which the balloon is coated with a hydrogel polymer matrix having a drug embedded therein.
In yet another aspect, the invention generally features a method for delivering a drug internally to a patient's body by providing the above-described device;
3 uncovering the balloon by pushing the balloon out of the opening of the sheath; preparing the balloon by introducing the drug to the surface of the balloon; and covering the balloon by pulling the balloon back through ' 5 the opening of the sheath until the balloon is proximal of the sheath opening. The method also may include steps such as inserting the device into the body to position the balloon at a desired location of drug delivery;
delivering the drug to the body; and removing the device from the body.
Moreover, the outer surface of the balloon may be covered with a hydrogel coating before the uncovering step, and the preparing step may comprise introducing the drug to the hydrogel coating. In another embodiment, the outer surface of the balloon may be covered with both a hydrogel coating and the drug during the preparing step.
The balloon also may be expanded within the sheath to form a seal between the outer surface of the balloon and the inner surface of the sheath. This helps to prevents bodily fluids from flowing into the sheath.
If the sheath has a tab, the method may include the steps of covering the balloon by holding the tab and pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening and detaching the tab from the sheath. The detaching step may include tearing the sheath along the pre-formed cuts located where the tab is attached to the sheath.
Other features and advantages will be apparent from the following drawings, description of the preferred embodiments and claims.
delivering the drug to the body; and removing the device from the body.
Moreover, the outer surface of the balloon may be covered with a hydrogel coating before the uncovering step, and the preparing step may comprise introducing the drug to the hydrogel coating. In another embodiment, the outer surface of the balloon may be covered with both a hydrogel coating and the drug during the preparing step.
The balloon also may be expanded within the sheath to form a seal between the outer surface of the balloon and the inner surface of the sheath. This helps to prevents bodily fluids from flowing into the sheath.
If the sheath has a tab, the method may include the steps of covering the balloon by holding the tab and pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening and detaching the tab from the sheath. The detaching step may include tearing the sheath along the pre-formed cuts located where the tab is attached to the sheath.
Other features and advantages will be apparent from the following drawings, description of the preferred embodiments and claims.
- 4 -Brief Description of the Drawing Fig. 1 is a side view, partially in section, of a device for delivering a drug internally to a patient's body.
Fig. 1(a) is a cross-sectional view along lines 1(a)-1(a) in Fig. 1.
Fig. 2 is a cross-sectional view along lines 2-2 in Fig. 1.
Fig. 3 is a cross-sectional view along lines 3-3 l0 in Fig. 1.
Figs. 4-9 show the steps of delivering a drug internally to the patient's body using the device in Fig.
1.
Description of the Preferred Embodiments Referring to Figs. 1-3, a drug delivery balloon catheter device 1 includes a catheter 4 with a~catheter shaft 5 and an expandable balloon 6 attached to a distal end of catheter shaft 5. Device 1 also includes a flexible, thin-walled sheath 10 extending over balloon 6.
Sheath 10 helps to prevent the premature release of the drug during the positioning of balloon 6 at the desired location for drug delivery, for example, when sliding balloon 6 through a blood vessel.
Catheter shaft 5 is preferably very small in diameter and flexible. Catheter shaft 5 may be formed of hollow tubing to which balloon 6 is attached. Balloon 6 is preferably made from a compliant material such as polyethylene which conforms to the shape of the body lumen wall. Balloon 6 may also be made from other materials used in angioplasty, e.g., a nondistending material, such as polyethylene terephthalate (PET).
Balloon 6 has a swellable hydrogel polymer coating which can absorb a substantial amount of the drug, typically in aqueous solution form. The hydrogel polymer
Fig. 1(a) is a cross-sectional view along lines 1(a)-1(a) in Fig. 1.
Fig. 2 is a cross-sectional view along lines 2-2 in Fig. 1.
Fig. 3 is a cross-sectional view along lines 3-3 l0 in Fig. 1.
Figs. 4-9 show the steps of delivering a drug internally to the patient's body using the device in Fig.
1.
Description of the Preferred Embodiments Referring to Figs. 1-3, a drug delivery balloon catheter device 1 includes a catheter 4 with a~catheter shaft 5 and an expandable balloon 6 attached to a distal end of catheter shaft 5. Device 1 also includes a flexible, thin-walled sheath 10 extending over balloon 6.
Sheath 10 helps to prevent the premature release of the drug during the positioning of balloon 6 at the desired location for drug delivery, for example, when sliding balloon 6 through a blood vessel.
Catheter shaft 5 is preferably very small in diameter and flexible. Catheter shaft 5 may be formed of hollow tubing to which balloon 6 is attached. Balloon 6 is preferably made from a compliant material such as polyethylene which conforms to the shape of the body lumen wall. Balloon 6 may also be made from other materials used in angioplasty, e.g., a nondistending material, such as polyethylene terephthalate (PET).
Balloon 6 has a swellable hydrogel polymer coating which can absorb a substantial amount of the drug, typically in aqueous solution form. The hydrogel polymer
5 PCT/US98/00373 _ 5 _ coating is swellable and, in use, the hydrogel releases the drug. The hydrogel may itself be released from the surface of the balloon, or it may release the drug while generally remaining adhered to the balloon (see the X121 patent). Those of ordinary skill in the art will understand that there are a number of suitable hydrogel polymers that can be used, such as cross-linked polymer materials formed from the combination of a colloid and water.
The drug is preferably water soluble so that it may be easily absorbed into the hydrogel polymer coating.
The hydrogel polymer and drug preferably are not complexed, i.e., they are held together primarily if not exclusively through non-covalent association that results when the hydrogel polymer swells and absorbs the drug.
In other embodiments, however, it may be advantageous to select a hydrogel polymer coating for a particular drug such that the drug is not substantially released into bodily fluids before expanding balloon 6. Binding of the drug may be accomplished by electrostatic attraction of ~ the drug to the coating or a coating additive or by mechanical binding, e.g., using a coating having a pore size that inhibits inward flow of bodily fluids or outward f low of the drug .
The drug may be an antithrombogenic drug or an antiproliferative drug. Antithrombogenic drugs include heparin, PPack (dextrophenylalanine proline arginine chloromethylketone), enoxaprin, aspirin and hirudin.
Antiproliferative drugs include monoclonal antibodies capable of blocking smooth muscle cell proliferation, heparin, angiopeptin and exoxaprin.
The dosage applied to the tissue may be controlled by regulating the time of presoaking the drug into the hydrogel polymer coating to determine the amount of absorption of the drug solution by the hydrogel polymer WO 98f31415 PCT/US98/00373
The drug is preferably water soluble so that it may be easily absorbed into the hydrogel polymer coating.
The hydrogel polymer and drug preferably are not complexed, i.e., they are held together primarily if not exclusively through non-covalent association that results when the hydrogel polymer swells and absorbs the drug.
In other embodiments, however, it may be advantageous to select a hydrogel polymer coating for a particular drug such that the drug is not substantially released into bodily fluids before expanding balloon 6. Binding of the drug may be accomplished by electrostatic attraction of ~ the drug to the coating or a coating additive or by mechanical binding, e.g., using a coating having a pore size that inhibits inward flow of bodily fluids or outward f low of the drug .
The drug may be an antithrombogenic drug or an antiproliferative drug. Antithrombogenic drugs include heparin, PPack (dextrophenylalanine proline arginine chloromethylketone), enoxaprin, aspirin and hirudin.
Antiproliferative drugs include monoclonal antibodies capable of blocking smooth muscle cell proliferation, heparin, angiopeptin and exoxaprin.
The dosage applied to the tissue may be controlled by regulating the time of presoaking the drug into the hydrogel polymer coating to determine the amount of absorption of the drug solution by the hydrogel polymer WO 98f31415 PCT/US98/00373
- 6 -coating. Other factors affecting the dosage are the concentration of the drug in the solution applied to the coating and the releasability of the hydrogel polymer coating determined by, for example, the thickness of the hydrogel polymer coating, its resiliency, porosity and the ability of the hydrogel polymer coating to retain the drug.
To protect against premature release of the drug and hydrogel, catheter 4 is covered by sheath 10 during the positioning of balloon 6 at the desired location for drug delivery. Sheath 10 is flexible and has a thickness of no more than 0.04 French. Thus, sheath 10 increases the outer diameter of catheter 4 by only approximately 0.1 French. Although sheath 10 is preferably made from polyethylene terephthalate (PET), sheath 10 also may be made from nylon or polyester. Thus, the flexibility and outer diameter of catheter 4 are only minimally affected by the addition of sheath 10.
Sheath 10 has a balloon-enveloping portion 12 and a collar 14. Balloon-enveloping portion 12 has an inner diameter sized to fit closely around folded balloon 6.
Collar 14 is distal to, and has an inner diameter slightly smaller than the inner diameter of, the balloon-enveloping portion 12. Collar 14 terminates in an opening 16. The slightly smaller inner diameter of collar 14 helps to prevent balloon 6 from sliding out of opening 16 during the positioning of balloon 6 at the desired location for drug delivery.
Sheath 10 also has indentations 20 in the wall of sheath 10 located at a distal end of balloon-enveloping portion 12. Indentations 20 help to prevent balloon 6 from sliding out of opening 16 during the positioning of balloon 6 at the desired location for drug delivery.
Indentations 20 are molded into the wall of sheath 10 and are transverse to the balloon axis. Indentations 20 may be straightened out temporarily by pulling on the wall of sheath 10.
Sheath 10 also includes a tab 22 extending distally from the wall of sheath 10. Tab 22 may be used to adjust sheath 10 with respect to catheter 4. As described below, tab 22 should be removed from sheath 10 before insertion into the patient's body. Removal is achieved by tearing along pre-formed cuts 24 in the wall of sheath 10, located where tab 22 is attached to sheath 10.
Finally, device 1 may include a relatively stiff tubing 26 and adapter 28 disposed at the proximal end (outside the patient's body) for a better seal between sheath 10 and catheter 4.
II. Use Referring to Figs. 4-9, a drug may be delivered internally to the patient's body using device 1 as follows. Drug and hydrogel coating typically are added to the balloon surface shortly before the device is inserted into the patient's body. First, balloon 6 is exposed by pushing it out of opening 16 of sheath 10.
Balloon 6 is expanded, and a drug in an aqueous solution is absorbed into the hydrogel polymer coating, for example by immersing it in a small vial 7 containing the drug, as shown in Fig. 4. Alternatively, the drug may be applied to the balloon in the fprm of droplets from an eyedropper, or it may be precipitated into the hydrogel polymer coating before sterilization and the coated balloon catheter is sold as a finished device.
After balloon 6 is dried and deflated, balloon 6 is covered with sheath 10 by pulling balloon 6 back into sheath 10 while holding tab 22, as shown in Fig. 5.
Balloon 6 is positioned within sheath 10, so that balloon 6 is proximal of collar 14 of sheath l0. Tab 22 is detached from sheath 10 by tearing or cutting along pre-_ g _ formed cuts 24 (Fig. 6) before inserting the device into the patient.
Although tab 22 is helpful in manipulating the flexible, thin-walled sheath, other embodiments of the invention may describe other ways for adjusting the relative positions of the sheath and balloon. For example, the balloon may be pulled back into the sheath by using forceps to hold the sheath. In another embodiment, the balloon may be covered with the sheath by unrolling the sheath over the balloon.
After balloon 6 is positioned within sheath 10, balloon may be slightly expanded so that the outer surface of balloon 6 contacts with the inner surface of sheath 10, thereby forming a seal between the outer surface of balloon 6 with the inner surface of sheath 10.
This helps to prevent bodily fluids from flowing into sheath 10. Balloon 6 is then deflated.
In Fig. 7, device 1 is inserted into a blood vessel having a region to be treated, such as an occlusion due to deposits of plaque on the vessel wall tissue. Device 1 is moved along the vessel to position balloon 6 at the desired location for drug delivery.
Referring to Fig. 8, after balloon 6 is positioned at desired location for drug delivery, balloon 6 is uncovered by pulling on sheath 10 while maintaining balloon 6 in position. Balloon.6 slides out of opening 16 of sheath 10. As balloon 6 is expanded, the drug is released for transfer into the plaque and tissue. As shown in Fig. 9, the pressure applied to the plaque and tissue by the expansion of balloon 6 enhances the transfer of the drug into the plaque and tissue. After the drug is delivered to the tissue, balloon 6 is deflated and removed from the patient s body.
To protect against premature release of the drug and hydrogel, catheter 4 is covered by sheath 10 during the positioning of balloon 6 at the desired location for drug delivery. Sheath 10 is flexible and has a thickness of no more than 0.04 French. Thus, sheath 10 increases the outer diameter of catheter 4 by only approximately 0.1 French. Although sheath 10 is preferably made from polyethylene terephthalate (PET), sheath 10 also may be made from nylon or polyester. Thus, the flexibility and outer diameter of catheter 4 are only minimally affected by the addition of sheath 10.
Sheath 10 has a balloon-enveloping portion 12 and a collar 14. Balloon-enveloping portion 12 has an inner diameter sized to fit closely around folded balloon 6.
Collar 14 is distal to, and has an inner diameter slightly smaller than the inner diameter of, the balloon-enveloping portion 12. Collar 14 terminates in an opening 16. The slightly smaller inner diameter of collar 14 helps to prevent balloon 6 from sliding out of opening 16 during the positioning of balloon 6 at the desired location for drug delivery.
Sheath 10 also has indentations 20 in the wall of sheath 10 located at a distal end of balloon-enveloping portion 12. Indentations 20 help to prevent balloon 6 from sliding out of opening 16 during the positioning of balloon 6 at the desired location for drug delivery.
Indentations 20 are molded into the wall of sheath 10 and are transverse to the balloon axis. Indentations 20 may be straightened out temporarily by pulling on the wall of sheath 10.
Sheath 10 also includes a tab 22 extending distally from the wall of sheath 10. Tab 22 may be used to adjust sheath 10 with respect to catheter 4. As described below, tab 22 should be removed from sheath 10 before insertion into the patient's body. Removal is achieved by tearing along pre-formed cuts 24 in the wall of sheath 10, located where tab 22 is attached to sheath 10.
Finally, device 1 may include a relatively stiff tubing 26 and adapter 28 disposed at the proximal end (outside the patient's body) for a better seal between sheath 10 and catheter 4.
II. Use Referring to Figs. 4-9, a drug may be delivered internally to the patient's body using device 1 as follows. Drug and hydrogel coating typically are added to the balloon surface shortly before the device is inserted into the patient's body. First, balloon 6 is exposed by pushing it out of opening 16 of sheath 10.
Balloon 6 is expanded, and a drug in an aqueous solution is absorbed into the hydrogel polymer coating, for example by immersing it in a small vial 7 containing the drug, as shown in Fig. 4. Alternatively, the drug may be applied to the balloon in the fprm of droplets from an eyedropper, or it may be precipitated into the hydrogel polymer coating before sterilization and the coated balloon catheter is sold as a finished device.
After balloon 6 is dried and deflated, balloon 6 is covered with sheath 10 by pulling balloon 6 back into sheath 10 while holding tab 22, as shown in Fig. 5.
Balloon 6 is positioned within sheath 10, so that balloon 6 is proximal of collar 14 of sheath l0. Tab 22 is detached from sheath 10 by tearing or cutting along pre-_ g _ formed cuts 24 (Fig. 6) before inserting the device into the patient.
Although tab 22 is helpful in manipulating the flexible, thin-walled sheath, other embodiments of the invention may describe other ways for adjusting the relative positions of the sheath and balloon. For example, the balloon may be pulled back into the sheath by using forceps to hold the sheath. In another embodiment, the balloon may be covered with the sheath by unrolling the sheath over the balloon.
After balloon 6 is positioned within sheath 10, balloon may be slightly expanded so that the outer surface of balloon 6 contacts with the inner surface of sheath 10, thereby forming a seal between the outer surface of balloon 6 with the inner surface of sheath 10.
This helps to prevent bodily fluids from flowing into sheath 10. Balloon 6 is then deflated.
In Fig. 7, device 1 is inserted into a blood vessel having a region to be treated, such as an occlusion due to deposits of plaque on the vessel wall tissue. Device 1 is moved along the vessel to position balloon 6 at the desired location for drug delivery.
Referring to Fig. 8, after balloon 6 is positioned at desired location for drug delivery, balloon 6 is uncovered by pulling on sheath 10 while maintaining balloon 6 in position. Balloon.6 slides out of opening 16 of sheath 10. As balloon 6 is expanded, the drug is released for transfer into the plaque and tissue. As shown in Fig. 9, the pressure applied to the plaque and tissue by the expansion of balloon 6 enhances the transfer of the drug into the plaque and tissue. After the drug is delivered to the tissue, balloon 6 is deflated and removed from the patient s body.
Claims (16)
1. A medical device for delivering a drug internally to a patient's body comprising:
a catheter with a catheter shaft and a balloon attached to a distal end of the catheter shaft; and a flexible, thin-walled sheath extending over the balloon, wherein the sheath includes a balloon-enveloping portion having an inner diameter sized to fit closely around the balloon, and a collar distal to, and having an inner diameter slightly smaller than the inner diameter of, the balloon-enveloping portion, the collar terminating in an opening.
a catheter with a catheter shaft and a balloon attached to a distal end of the catheter shaft; and a flexible, thin-walled sheath extending over the balloon, wherein the sheath includes a balloon-enveloping portion having an inner diameter sized to fit closely around the balloon, and a collar distal to, and having an inner diameter slightly smaller than the inner diameter of, the balloon-enveloping portion, the collar terminating in an opening.
2. The device of claim 1 further comprising a tab extending distally from the wall of the sheath.
3. The device of claim 2 wherein the tab is a continuation of part of the wall of the sheath.
4. The device of claim 2 wherein the sheath has pre-formed cuts located where the tab is attached to the sheath.
5. The device of claim 4 wherein the tab is detachable from the sheath by tearing the sheath along the pre-formed cuts.
6. The device of claim 1 wherein the sheath has indentations located at the balloon-enveloping portion to engage the balloon.
7. The device of claim 1 wherein the wall of the sheath has a thickness of no more than 0.04 French.
8. The device of claim 1 wherein the sheath is made from polyester, nylon or polyethylene terephthalate (PET).
9. The device of claim 1 wherein the balloon is coated with a hydrogel polymer matrix having a drug embedded therein.
10. A method for delivering a drug internally to a patient's body comprising:
providing the device of claim 1;
uncovering the balloon by pushing the balloon out of the opening of the sheath;
preparing the balloon by introducing the drug to the surface of the balloon; and covering the balloon by pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening.
providing the device of claim 1;
uncovering the balloon by pushing the balloon out of the opening of the sheath;
preparing the balloon by introducing the drug to the surface of the balloon; and covering the balloon by pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening.
11. The method of claim 10 further comprising:
inserting the device into the body to position the balloon at a desired location of drug delivery;
delivering the drug to the body; and removing the device from the body.
inserting the device into the body to position the balloon at a desired location of drug delivery;
delivering the drug to the body; and removing the device from the body.
12. The method of claim 10 wherein the outer surface of the balloon is covered with a hydrogel coating before the uncovering step, and the preparing step comprises introducing the drug to the hydrogel coating.
13. The method of claim 10 wherein the outer surface of the balloon is covered with both a hydrogel coating and the drug during the preparing step.
14. The method of claim 10 further comprising expanding the balloon within the sheath to form a seal between the outer surface of the balloon and the inner surface of the sheath.
15. A method for delivering a drug internally to a patient s body comprising:
providing the device of claim 2;
uncovering the balloon by pushing the balloon out of the opening of the sheath;
preparing the balloon by introducing a drug to the surface of the balloon;
covering the balloon by holding the tab and pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening; and detaching the tab from the sheath.
providing the device of claim 2;
uncovering the balloon by pushing the balloon out of the opening of the sheath;
preparing the balloon by introducing a drug to the surface of the balloon;
covering the balloon by holding the tab and pulling the balloon back through the opening of the sheath until the balloon is proximal of the sheath opening; and detaching the tab from the sheath.
16. The method of claim 14 wherein the detaching step comprises tearing the sheath along pre-formed cuts located where the tab is attached to the sheath.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/782,684 US5868719A (en) | 1997-01-15 | 1997-01-15 | Drug delivery balloon catheter device |
| US08/782,684 | 1997-01-15 | ||
| PCT/US1998/000373 WO1998031415A1 (en) | 1997-01-15 | 1998-01-12 | Drug delivery balloon catheter device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2277770A1 true CA2277770A1 (en) | 1998-07-23 |
Family
ID=25126855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002277770A Abandoned CA2277770A1 (en) | 1997-01-15 | 1998-01-12 | Drug delivery balloon catheter device |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5868719A (en) |
| EP (1) | EP1007135B1 (en) |
| AT (1) | ATE267029T1 (en) |
| CA (1) | CA2277770A1 (en) |
| DE (1) | DE69824011T2 (en) |
| WO (1) | WO1998031415A1 (en) |
Families Citing this family (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6958059B2 (en) | 1996-05-20 | 2005-10-25 | Medtronic Ave, Inc. | Methods and apparatuses for drug delivery to an intravascular occlusion |
| US6165158A (en) | 1998-10-14 | 2000-12-26 | Advanced Cardiovascular Systems, Inc. | Lubricious catheter shaft |
| US6395208B1 (en) | 1999-01-25 | 2002-05-28 | Atrium Medical Corporation | Method of making an expandable fluoropolymer device |
| US7637886B2 (en) * | 1999-01-25 | 2009-12-29 | Atrium Medical Corporation | Expandable fluoropolymer device and method of making |
| US6955661B1 (en) * | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
| US6364867B2 (en) * | 1999-07-01 | 2002-04-02 | Catheter Innovations, Inc. | Anti-clotting methods and apparatus for indwelling catheter tubes |
| US8172783B1 (en) | 1999-12-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc | Conduit system for isolation of fluids in biological tissues |
| US9522217B2 (en) * | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| US8088060B2 (en) * | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US20050271701A1 (en) * | 2000-03-15 | 2005-12-08 | Orbus Medical Technologies, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US6471968B1 (en) | 2000-05-12 | 2002-10-29 | Regents Of The University Of Michigan | Multifunctional nanodevice platform |
| US7481790B2 (en) * | 2000-12-27 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Vessel enlargement by arteriogenic factor delivery |
| DE10115740A1 (en) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Preparation for restenosis prophylaxis |
| US6796960B2 (en) * | 2001-05-04 | 2004-09-28 | Wit Ip Corporation | Low thermal resistance elastic sleeves for medical device balloons |
| WO2003041760A2 (en) | 2001-11-09 | 2003-05-22 | Novoste Corporation | Baloon catheter with non-deployable stent |
| US20040111108A1 (en) | 2001-11-09 | 2004-06-10 | Farnan Robert C. | Balloon catheter with non-deployable stent |
| CA2476263C (en) * | 2002-02-01 | 2012-08-21 | Robert J. Goldman | Multi-function catheter and use thereof |
| US20050267407A1 (en) * | 2002-02-01 | 2005-12-01 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
| US8062251B2 (en) * | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
| US20030236506A1 (en) * | 2002-06-20 | 2003-12-25 | Eric Schofield | Dual outside diameter cannula for insertion into bone |
| EP1521603B1 (en) | 2002-07-12 | 2011-01-19 | Cook Incorporated | Coated medical device |
| DE10244847A1 (en) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medical device for drug delivery |
| US7686824B2 (en) * | 2003-01-21 | 2010-03-30 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
| US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
| US8740844B2 (en) * | 2003-08-20 | 2014-06-03 | Boston Scientific Scimed, Inc. | Medical device with drug delivery member |
| WO2005027996A2 (en) * | 2003-09-15 | 2005-03-31 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
| EP2417906B1 (en) * | 2003-10-10 | 2015-04-15 | Given Imaging (Los Angeles) LLC | Method of configuring a pressure sensing catheter, and catheter sheath |
| US9241735B2 (en) * | 2003-12-05 | 2016-01-26 | Onset Medical Corporation | Expandable percutaneous sheath |
| US7349971B2 (en) * | 2004-02-05 | 2008-03-25 | Scenera Technologies, Llc | System for transmitting data utilizing multiple communication applications simultaneously in response to user request without specifying recipient's communication information |
| CA2578205A1 (en) * | 2004-08-25 | 2006-03-30 | The Regents Of The University Of Michigan | Partially acetylated dendrimers and related methods of use |
| US7892203B2 (en) * | 2004-09-09 | 2011-02-22 | Onset Medical Corporation | Expandable transluminal sheath |
| JP4938668B2 (en) | 2004-09-09 | 2012-05-23 | オンセット メディカル コーポレイション | Expandable transluminal sheath |
| US20060083770A1 (en) * | 2004-10-15 | 2006-04-20 | Specialty Coating Systems, Inc. | Medical devices and methods of preparation and use |
| US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
| US20070041934A1 (en) * | 2005-08-12 | 2007-02-22 | Regents Of The University Of Michigan | Dendrimer based compositions and methods of using the same |
| US20070148390A1 (en) * | 2005-12-27 | 2007-06-28 | Specialty Coating Systems, Inc. | Fluorinated coatings |
| US20080243068A1 (en) * | 2005-12-29 | 2008-10-02 | Kamal Ramzipoor | Methods and apparatus for treatment of venous insufficiency |
| US20070295337A1 (en) * | 2006-06-22 | 2007-12-27 | Nelson Donald S | Endotracheal cuff and technique for using the same |
| US8196584B2 (en) | 2006-06-22 | 2012-06-12 | Nellcor Puritan Bennett Llc | Endotracheal cuff and technique for using the same |
| US8434487B2 (en) | 2006-06-22 | 2013-05-07 | Covidien Lp | Endotracheal cuff and technique for using the same |
| US20070296125A1 (en) * | 2006-06-22 | 2007-12-27 | Joel Colburn | Thin cuff for use with medical tubing and method and apparatus for making the same |
| NZ574597A (en) * | 2006-07-03 | 2011-11-25 | Hemoteq Ag | Stent coated with a biodegradable polymer and rapamycin |
| US7654264B2 (en) | 2006-07-18 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical tube including an inflatable cuff having a notched collar |
| US20080053454A1 (en) * | 2006-09-01 | 2008-03-06 | Nellcor Puritan Bennett Incorporated | Endotracheal tube including a partially inverted cuff collar |
| US8684175B2 (en) | 2006-09-22 | 2014-04-01 | Covidien Lp | Method for shipping and protecting an endotracheal tube with an inflated cuff |
| US8561614B2 (en) * | 2006-09-28 | 2013-10-22 | Covidien Lp | Multi-layer cuffs for medical devices |
| US20080078399A1 (en) | 2006-09-29 | 2008-04-03 | O'neil Michael P | Self-sizing adjustable endotracheal tube |
| US7950393B2 (en) * | 2006-09-29 | 2011-05-31 | Nellcor Puritan Bennett Llc | Endotracheal cuff and technique for using the same |
| US20080078405A1 (en) * | 2006-09-29 | 2008-04-03 | Crumback Gary L | Self-sizing adjustable endotracheal tube |
| US8807136B2 (en) * | 2006-09-29 | 2014-08-19 | Covidien Lp | Self-sizing adjustable endotracheal tube |
| US8307830B2 (en) | 2006-09-29 | 2012-11-13 | Nellcor Puritan Bennett Llc | Endotracheal cuff and technique for using the same |
| US20080078401A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | Self-sizing adjustable endotracheal tube |
| US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| US8414910B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
| US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
| US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
| US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
| US20080175887A1 (en) * | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
| US20080140002A1 (en) * | 2006-12-06 | 2008-06-12 | Kamal Ramzipoor | System for delivery of biologically active substances with actuating three dimensional surface |
| US20080140022A1 (en) * | 2006-12-08 | 2008-06-12 | Warsaw Orthopedic, Inc. | Coated Cannula with Protective Tip for Insertion Into a Patient |
| NZ588816A (en) * | 2007-01-21 | 2011-11-25 | Hemoteq Ag | Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses |
| US20080215034A1 (en) * | 2007-03-02 | 2008-09-04 | Jessica Clayton | Endotracheal cuff and technique for using the same |
| US20080210243A1 (en) * | 2007-03-02 | 2008-09-04 | Jessica Clayton | Endotracheal cuff and technique for using the same |
| AU2008275501A1 (en) * | 2007-04-19 | 2009-01-15 | The Regents Of The University Of Michigan | Dendrimer based compositions and methods of using the same |
| US9370642B2 (en) | 2007-06-29 | 2016-06-21 | J.W. Medical Systems Ltd. | Adjustable-length drug delivery balloon |
| US9192697B2 (en) * | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
| CN101896221B (en) | 2007-12-11 | 2013-06-05 | 麻省理工学院 | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens |
| US8750978B2 (en) * | 2007-12-31 | 2014-06-10 | Covidien Lp | System and sensor for early detection of shock or perfusion failure and technique for using the same |
| WO2009151687A2 (en) | 2008-03-12 | 2009-12-17 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| US8049061B2 (en) | 2008-09-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery |
| US8076529B2 (en) * | 2008-09-26 | 2011-12-13 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix for intraluminal drug delivery |
| US8226603B2 (en) * | 2008-09-25 | 2012-07-24 | Abbott Cardiovascular Systems Inc. | Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery |
| US8500687B2 (en) | 2008-09-25 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
| US8889635B2 (en) | 2008-09-30 | 2014-11-18 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| US9017644B2 (en) | 2008-11-07 | 2015-04-28 | The Regents Of The University Of Michigan | Methods of treating autoimmune disorders and/or inflammatory disorders |
| US8590534B2 (en) * | 2009-06-22 | 2013-11-26 | Covidien Lp | Cuff for use with medical tubing and method and apparatus for making the same |
| DK2445571T3 (en) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Solid drug tablets for implantable drug delivery devices |
| US8828040B2 (en) * | 2009-07-07 | 2014-09-09 | Thomas G. Goff | Device and methods for delivery and transfer of temporary radiopaque element |
| WO2011005421A2 (en) | 2009-07-10 | 2011-01-13 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
| EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| CN102917699A (en) | 2009-10-13 | 2013-02-06 | 密执安大学评议会 | Dendrimer compositions and methods of synthesis |
| WO2011059586A2 (en) | 2009-10-30 | 2011-05-19 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| WO2011072398A1 (en) * | 2009-12-18 | 2011-06-23 | Interface Biologics, Inc. | Local delivery of drugs from self assembled coatings |
| US9199066B2 (en) * | 2010-03-12 | 2015-12-01 | Quattro Vascular Pte Ltd. | Device and method for compartmental vessel treatment |
| EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
| US9943668B2 (en) | 2010-07-16 | 2018-04-17 | Sub3 Vascular, Llc | Guidewire and catheter system and method for treating a blood clot |
| EP3711750B1 (en) | 2010-08-05 | 2023-09-06 | TARIS Biomedical LLC | Implantable drug delivery devices for genitourinary sites |
| EP2611476B1 (en) | 2010-09-02 | 2016-08-10 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
| US8632559B2 (en) | 2010-09-21 | 2014-01-21 | Angioscore, Inc. | Method and system for treating valve stenosis |
| WO2013022458A1 (en) | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| WO2013028208A1 (en) | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| US9402911B2 (en) | 2011-12-08 | 2016-08-02 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| WO2013114201A1 (en) | 2012-02-01 | 2013-08-08 | Tanhum Feld | Device for compartmental dilatation of blood vessels |
| US9216033B2 (en) | 2012-02-08 | 2015-12-22 | Quattro Vascular Pte Ltd. | System and method for treating biological vessels |
| SG11201403915XA (en) | 2012-02-08 | 2014-08-28 | Quattro Vascular Pte Ltd | Constraining structure with non-linear axial struts |
| JP6517186B2 (en) | 2013-03-15 | 2019-05-22 | タリス バイオメディカル エルエルシー | Drug delivery device comprising a drug permeable component and method |
| CN105307716B (en) | 2013-05-03 | 2021-09-14 | C·R·巴德公司 | Strippable protective sleeve |
| AU2014309012B2 (en) | 2013-08-19 | 2019-03-14 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
| WO2015077545A1 (en) | 2013-11-24 | 2015-05-28 | Cordis Corporation | Drug delivery system |
| EP2906613B1 (en) | 2014-01-13 | 2016-03-16 | Yang, Guanghua | Dendrimer compositions, methods of synthesis, and uses thereof |
| EP3125866B1 (en) | 2014-04-04 | 2021-03-03 | President and Fellows of Harvard College | Refillable drug delivery devices and methods of use thereof |
| US10232148B2 (en) | 2014-11-17 | 2019-03-19 | TriReme Medical, LLC | Balloon catheter system and method of using same |
| CA2979712C (en) | 2015-03-25 | 2024-01-23 | The Regents Of The University Of Michigan | Nanoparticle compositions for delivery of biomacromolecules |
| JP7425534B2 (en) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | Drug delivery devices and methods with drug permeable components |
| US11186641B2 (en) | 2016-03-17 | 2021-11-30 | Oslo Universitetssykehus Hf | Fusion proteins targeting tumour associated macrophages for treating cancer |
| US20190358263A1 (en) | 2016-12-07 | 2019-11-28 | Oslo Universitetssykehus Hf | Compositions and Methods for Cell Therapy |
| CN109381783A (en) * | 2017-08-02 | 2019-02-26 | 杭州唯强医疗科技有限公司 | Drug coated balloon catheter |
| US10668255B2 (en) | 2018-01-19 | 2020-06-02 | Medtronic Vascular, Inc. | Sheath for medically expandable balloon |
| US10737071B2 (en) | 2018-01-19 | 2020-08-11 | Medtronic, Inc. | Splittable sheath |
| US10702673B2 (en) | 2018-01-19 | 2020-07-07 | Medtronic Vascular, Inc. | Expandable balloon sheaths |
| US10682492B2 (en) | 2018-01-19 | 2020-06-16 | Medtronic Vascular, Inc. | Expandable balloon sheath |
| US10688287B2 (en) | 2018-01-19 | 2020-06-23 | Medtronic, Inc. | Sheath including sheath body and sheath insert |
| WO2019195641A2 (en) | 2018-04-06 | 2019-10-10 | The Regents Of The University Of Michigan | Inhibitors of rho/mrtf/srf-mediated gene transcription and methods for use of the same |
| EP3796948A4 (en) | 2018-05-22 | 2022-03-02 | Interface Biologics Inc. | Compositions and methods for delivering drugs to a vessel wall |
| US11389627B1 (en) | 2018-10-02 | 2022-07-19 | Lutonix Inc. | Balloon protectors, balloon-catheter assemblies, and methods thereof |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE380205C (en) * | 1921-09-29 | 1924-01-19 | Julius Frankenstein Dr | Device for the therapeutic treatment of human body cavities with an airtight rubber jacket on an air supply tube |
| DE1196327B (en) * | 1963-04-06 | 1965-07-08 | Willy Ruesch Fa | catheter |
| US3699956A (en) * | 1970-10-01 | 1972-10-24 | Tecna Corp | Percutaneous lead device |
| CS173836B1 (en) * | 1974-03-19 | 1977-03-31 | ||
| JPS5950335B2 (en) * | 1976-07-06 | 1984-12-07 | 東洋紡績株式会社 | Manufacturing method of anti-blood coagulation medical soft material |
| JPS5435036A (en) * | 1977-08-13 | 1979-03-14 | Sumitomo Electric Industries | Irrigation device |
| US4299226A (en) * | 1979-08-08 | 1981-11-10 | Banka Vidya S | Coronary dilation method |
| US4481323A (en) * | 1980-05-07 | 1984-11-06 | Medical Research Associates, Ltd. #2 | Hydrocarbon block copolymer with dispersed polysiloxane |
| US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
| US4330497A (en) * | 1981-01-19 | 1982-05-18 | Sherwood Medical Industries Inc. | Method of making grooved plastic medical tubing |
| US4448195A (en) * | 1981-05-08 | 1984-05-15 | Leveen Harry H | Reinforced balloon catheter |
| CA1191064A (en) * | 1981-12-31 | 1985-07-30 | Bard (C. R.), Inc. | Catheter with selectively rigidified portion |
| US4515593A (en) * | 1981-12-31 | 1985-05-07 | C. R. Bard, Inc. | Medical tubing having exterior hydrophilic coating for microbiocide absorption therein and method for using same |
| US4417576A (en) * | 1982-02-25 | 1983-11-29 | Baran Ostap E | Double-wall surgical cuff |
| US4423725A (en) * | 1982-03-31 | 1984-01-03 | Baran Ostap E | Multiple surgical cuff |
| US4636195A (en) * | 1982-04-02 | 1987-01-13 | Harvey Wolinsky | Method and apparatus for removing arterial constriction |
| US4769013A (en) * | 1982-09-13 | 1988-09-06 | Hydromer, Inc. | Bio-effecting medical material and device |
| SU1069826A1 (en) * | 1982-09-17 | 1984-01-30 | Запорожский медицинский институт | Endotracheal tube |
| WO1984001513A1 (en) * | 1982-10-08 | 1984-04-26 | David Hardcastle | Balloon catheter and process for the manufacture thereof |
| US4603152A (en) * | 1982-11-05 | 1986-07-29 | Baxter Travenol Laboratories, Inc. | Antimicrobial compositions |
| US4693243A (en) * | 1983-01-14 | 1987-09-15 | Buras Sharon Y | Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas |
| US4714460A (en) * | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
| US4592340A (en) * | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
| US4589873A (en) * | 1984-05-29 | 1986-05-20 | Becton, Dickinson And Company | Method of applying a hydrophilic coating to a polymeric substrate and articles prepared thereby |
| EP0166998B1 (en) * | 1984-06-04 | 1991-05-08 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Medical instrument and method for making |
| US4732930A (en) * | 1985-05-20 | 1988-03-22 | Massachusetts Institute Of Technology | Reversible, discontinuous volume changes of ionized isopropylacrylamide cells |
| JPS62236560A (en) * | 1986-04-09 | 1987-10-16 | テルモ株式会社 | Catheter for repairing blood vessel |
| US4784647A (en) * | 1986-07-30 | 1988-11-15 | The Kendal Company | Catheter meatal pad device |
| JPS6415056A (en) * | 1987-07-09 | 1989-01-19 | Hanarou Maeda | Body indwelling tube |
| JPH01171571A (en) * | 1987-12-28 | 1989-07-06 | Yoshiharu Yamawaki | Balloon catheter |
| US4950256A (en) * | 1988-04-07 | 1990-08-21 | Luther Medical Products, Inc. | Non-thrombogenic intravascular time release catheter |
| JP2683750B2 (en) * | 1988-06-06 | 1997-12-03 | 住友電気工業株式会社 | Catheter balloon |
| DE3821544C2 (en) * | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
| US4909258A (en) * | 1988-08-08 | 1990-03-20 | The Beth Israel Hospital Association | Internal mammary artery (IMA) catheter |
| US5213580A (en) * | 1988-08-24 | 1993-05-25 | Endoluminal Therapeutics, Inc. | Biodegradable polymeric endoluminal sealing process |
| US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| CH676426A5 (en) * | 1988-09-27 | 1991-01-31 | Schneider Shiley Ag | |
| US5091205A (en) * | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
| US5021044A (en) * | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
| US5087244A (en) * | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
| US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5047045A (en) * | 1989-04-13 | 1991-09-10 | Scimed Life Systems, Inc. | Multi-section coaxial angioplasty catheter |
| US5041100A (en) * | 1989-04-28 | 1991-08-20 | Cordis Corporation | Catheter and hydrophilic, friction-reducing coating thereon |
| US4994033A (en) * | 1989-05-25 | 1991-02-19 | Schneider (Usa) Inc. | Intravascular drug delivery dilatation catheter |
| US5026607A (en) * | 1989-06-23 | 1991-06-25 | C. R. Bard, Inc. | Medical apparatus having protective, lubricious coating |
| US4993412A (en) * | 1989-08-02 | 1991-02-19 | Eclipse Surgical Technologies, Inc. | Method and apparatus for removal of obstructive substance from body channels |
| JPH05501276A (en) * | 1989-10-23 | 1993-03-11 | マサチユセツツ・インスチチユート・オブ・テクノロジー | Photoinduced reversible discontinuous volume change of gels |
| US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
| US5439446A (en) * | 1994-06-30 | 1995-08-08 | Boston Scientific Corporation | Stent and therapeutic delivery system |
| US5135516A (en) * | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
| US5304121A (en) * | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| US5049132A (en) * | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
| DK0441516T3 (en) * | 1990-02-08 | 1995-06-12 | Howmedica | Inflatable catheter |
| US5120322A (en) * | 1990-06-13 | 1992-06-09 | Lathrotec, Inc. | Method and apparatus for treatment of fibrotic lesions |
| US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
| WO1992011895A1 (en) * | 1990-12-28 | 1992-07-23 | Boston Scientific Corporation | Balloon drug delivery system |
| CA2098984C (en) * | 1990-12-28 | 2002-03-05 | Ronald Sahatjian | Drug delivery system |
| US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
| US5324261A (en) * | 1991-01-04 | 1994-06-28 | Medtronic, Inc. | Drug delivery balloon catheter with line of weakness |
| WO1992013566A1 (en) * | 1991-01-31 | 1992-08-20 | Massachusetts Institute Of Technology | Interpenetrating-polymer network phase-transition gels |
| US5171217A (en) * | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
| US5213576A (en) * | 1991-06-11 | 1993-05-25 | Cordis Corporation | Therapeutic porous balloon catheter |
| WO1993011751A1 (en) * | 1991-12-18 | 1993-06-24 | Scimed Life Systems, Inc. | Lubricous polymer network |
| US5336615A (en) * | 1992-01-06 | 1994-08-09 | Yale University | Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
| US5254089A (en) * | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
| US5246437A (en) * | 1992-04-10 | 1993-09-21 | Abela George S | Cell treatment apparatus and method |
| US5304120A (en) * | 1992-07-01 | 1994-04-19 | Btx Inc. | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
| US5634901A (en) * | 1992-11-02 | 1997-06-03 | Localmed, Inc. | Method of using a catheter sleeve |
| US5336178A (en) * | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
| WO1995026777A1 (en) * | 1994-04-01 | 1995-10-12 | Localmed, Inc. | Method and apparatus for performing multiple procedures |
| US5462752A (en) * | 1994-07-28 | 1995-10-31 | Prp, Inc. | Inhibition of platelet binding |
| ES1030202Y (en) * | 1995-02-20 | 1996-01-16 | Medina Fernandez Aceytuno Alfo | BALL CATHETER WITH IMPROVED TUBULAR DEVICE FOR USE IN THE TREATMENT OF VASCULAR STENOSIS. |
| US5730734A (en) * | 1996-11-14 | 1998-03-24 | Scimed Life Systems, Inc. | Catheter systems with interchangeable parts |
-
1997
- 1997-01-15 US US08/782,684 patent/US5868719A/en not_active Expired - Lifetime
-
1998
- 1998-01-12 EP EP98902444A patent/EP1007135B1/en not_active Expired - Lifetime
- 1998-01-12 DE DE69824011T patent/DE69824011T2/en not_active Expired - Lifetime
- 1998-01-12 AT AT98902444T patent/ATE267029T1/en not_active IP Right Cessation
- 1998-01-12 CA CA002277770A patent/CA2277770A1/en not_active Abandoned
- 1998-01-12 WO PCT/US1998/000373 patent/WO1998031415A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1007135B1 (en) | 2004-05-19 |
| DE69824011D1 (en) | 2004-06-24 |
| WO1998031415A1 (en) | 1998-07-23 |
| US5868719A (en) | 1999-02-09 |
| ATE267029T1 (en) | 2004-06-15 |
| EP1007135A4 (en) | 2000-12-06 |
| EP1007135A1 (en) | 2000-06-14 |
| DE69824011T2 (en) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5868719A (en) | Drug delivery balloon catheter device | |
| JP4691734B2 (en) | Device for selectively supplying a drug to a target position on the wall of a patient's body cavity, blood vessel or the like | |
| CA2201342C (en) | Polymeric medical device systems having shape memory | |
| CA2032689C (en) | Catheter | |
| US8794437B2 (en) | Packaged system including a protective housing for a treatment device carried on a catheter | |
| JP4436761B2 (en) | Device with expandable potion for drug release | |
| US6527740B1 (en) | Medical regrooming and drug delivery device | |
| US20010041883A1 (en) | Therapeutic device for the selective cytoreduction treatment of an obstruction in a natural lumen or passage of the human or animal body | |
| CA2229325A1 (en) | Delivery device for a medical device having a constricted region | |
| KR20060010827A (en) | Stent supplying device | |
| CA2324577A1 (en) | Rapid exchange self-expanding stent delivery catheter system | |
| WO2003045275A3 (en) | Medical device delivery system | |
| AU3342699A (en) | Delivery catheter | |
| JPH11178929A (en) | Balloon expansion drug delivery catheter and stent deployment drug delivery catheter in rapid exchange configuration | |
| JP2002537894A (en) | System for removably attaching a stent to a catheter assembly and method of use thereof | |
| JPH06503982A (en) | Methods for using and removable devices that can be used for self-management treatment of urinary tract infections or other diseases and can also be used as urethral plugs | |
| EP1648345A1 (en) | Self-expandable stent | |
| JP2003526449A (en) | Incontinence prevention equipment for women | |
| JPH08252321A (en) | Treatment tool carrying catheter | |
| EP1366731B1 (en) | A catheter for treating an intimal dissection | |
| US20030004534A1 (en) | Balloon transporter | |
| WO2023054320A1 (en) | Medical device and delivery system | |
| JPH10502269A (en) | Urinary incontinence prevention device and incontinence prevention law | |
| JP2022149382A (en) | Obstruction loaded catheter and medical instrument set | |
| MXPA96004820A (en) | A catheter for the release of farmaco pordilatac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |